相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Rhodamine labeling of 3-hydroxy-4-pyridinone iron chelators is an important contribution to target Mycobacterium avium infection
Tania Moniz et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2013)
Hydroxypyridinones as privileged chelating structures for the design of medicinal drugs
M. Amelia Santos et al.
COORDINATION CHEMISTRY REVIEWS (2012)
Chelating Agents for the Treatment of Systemic Iron Overload
Y. Ma et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Nickel(II) and Cobalt(II) 3-Hydroxy-4-pyridinone Complexes: Synthesis, Characterization and Speciation Studies in Aqueous Solution
Carla Queiros et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2011)
Investigation of the insulin-like properties of zinc(II) complexes of 3-hydroxy-4-pyridinones: Identification of a compound with glucose lowering effect in STZ-induced type I diabetic animals
Tania Moniz et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2011)
N-Aryl-substituted 3-(beta-D-glucopyranosyloxy)-2-methyl-4(1H)-pyridinones as agents for Alzheimer's therapy
Lauren E. Scott et al.
CHEMICAL SCIENCE (2011)
Copper-related diseases: From chemistry to molecular pathology
Guido Crisponi et al.
COORDINATION CHEMISTRY REVIEWS (2010)
In vitro studies of 3-hydroxy-4-pyridinones and their glycosylated derivatives as potential agents for Alzheimer's disease
David E. Green et al.
DALTON TRANSACTIONS (2010)
Fluorescent 3-hydroxy-4-pyridinone hexadentate iron chelators: intracellular distribution and the relevance to antimycobacterial properties
Ana Nunes et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2010)
Identification of a new hexadentate iron chelator capable of restricting the intramacrophagic growth of Mycobacterium avium
Sofia Sousa Fernandes et al.
MICROBES AND INFECTION (2010)
Altering pyridinone N-substituents to optimise activity as potential prodrugs for Alzheimer's disease
Lauren E. Scott et al.
DALTON TRANSACTIONS (2008)
Potential pathogenic role of beta-amyloid(1-42)-aluminum complex in Alzheimer's disease
Denise Drago et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
Antidiabetic copper(II)-picolinate: Impact of the first transition metal in the metallopicolinate complexes
Naoko Yasumatsu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
The discovery of vanadyl and zinc complexes for treating diabetes and metabolic syndromes
Hiromu Sakurai
EXPERT OPINION ON DRUG DISCOVERY (2007)
Vanadium in diabetes: 100 years from Phase 0 to Phase I
Katherine H. Thompson et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2006)
Spectroscopic and potentiometric characterization of oxovanadium(IV) complexes formed by 3-hydroxy-4-pyridinones.: Rationalization of the influence of basicity and electronic structure of the ligand on the properties of VIVO species in aqueous solution
Maria Rangel et al.
INORGANIC CHEMISTRY (2006)
The chemistry and biochemistry of vanadium and the biological activities exerted by vanadium compounds
DC Crans et al.
CHEMICAL REVIEWS (2004)
The metallobiology of Alzheimer's disease
AI Bush
TRENDS IN NEUROSCIENCES (2003)
The Cambridge Structural Database: a quarter of a million crystal structures and rising
FH Allen
ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE (2002)
Applications of the Cambridge Structural Database in organic chemistry and crystal chemistry
FH Allen et al.
ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE CRYSTAL ENGINEERING AND MATERIALS (2002)
分享论文
